American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,521 | 148,734 | 62,379 | 34,494 | 60,190 |
| Receivables | 96,093 | 98,604 | 110,608 | 105,401 | 103,930 |
| Inventories | 7,636 | 8,154 | 7,574 | 7,752 | 7,997 |
| Other current assets | 4,079 | 49,197 | 49,197 | 50,099 | 13,292 |
| TOTAL | $263,543 | $329,518 | $252,683 | $220,014 | $212,435 |
| Non-Current Assets | |||||
| PPE Net | 142,437 | 146,407 | 148,110 | 151,175 | 156,210 |
| Intangibles | 586,113 | 562,687 | 562,888 | 563,095 | 600,777 |
| Other Non-Current Assets | 168,108 | 161,087 | 160,365 | 152,507 | 148,523 |
| TOTAL | $896,658 | $870,181 | $871,363 | $866,777 | $905,510 |
| Total Assets | $1,160,201 | $1,199,699 | $1,124,046 | $1,086,791 | $1,117,945 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,931 | 36,047 | 38,011 | 38,779 | 41,430 |
| Accounts payable and accrued liabilities | 42,621 | 47,060 | 57,253 | 49,539 | 58,054 |
| Accrued Expenses | 148,913 | 211,351 | 80,598 | 74,789 | 89,556 |
| TOTAL | $251,178 | $321,869 | $203,079 | $190,935 | $211,262 |
| Non-Current Liabilities | |||||
| Long Term Debt | 538,788 | 549,100 | 579,882 | 548,835 | 551,999 |
| Other Non-Current Liabilities | 275,236 | 231,652 | 258,389 | 250,743 | 249,383 |
| TOTAL | $837,565 | $798,755 | $847,217 | $811,317 | $822,006 |
| Total Liabilities | $1,088,743 | $1,120,624 | $1,050,296 | $1,002,252 | $1,033,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,519 | 34,608 | 33,739 | 32,997 | 32,608 |
| Common Shares | 335 | 208 | 199 | 197 | 197 |
| Retained earnings | -187,371 | -184,680 | -185,475 | -178,241 | -178,331 |
| Other shareholders' equity | 148,673 | 151,663 | 156,237 | 161,839 | 158,140 |
| TOTAL | $71,458 | $79,075 | $73,750 | $84,539 | $84,677 |
| Total Liabilities And Equity | $1,160,201 | $1,199,699 | $1,124,046 | $1,086,791 | $1,117,945 |